These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29601990)

  • 1. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents.
    Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y
    Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents.
    Wang A; Ma C; Chai Y; Liu X; Lv K; Fu L; Wang B; Jia X; Liu M; Lu Y
    Eur J Med Chem; 2020 Aug; 200():112409. PubMed ID: 32460114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis.
    Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Ma C; Wang D; Wang A; Qin X; Liu M; Lu Y
    Eur J Med Chem; 2021 Jun; 218():113398. PubMed ID: 33823392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational design, synthesis and antitubercular evaluation of novel 2-(trifluoromethyl)phenothiazine-[1,2,3]triazole hybrids.
    Addla D; Jallapally A; Gurram D; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2014 Jan; 24(1):233-6. PubMed ID: 24314670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel benzothiopyranone compounds against Mycobacterium tuberculosis through scaffold morphing from benzothiazinones.
    Li P; Wang B; Zhang X; Batt SM; Besra GS; Zhang T; Ma C; Zhang D; Lin Z; Li G; Huang H; Lu Y
    Eur J Med Chem; 2018 Dec; 160():157-170. PubMed ID: 30336450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo antimicrobial activities of a novel piperazine-containing benzothiazinones candidate TZY-5-84 against Mycobacterium tuberculosis.
    Guo S; Fu L; Wang B; Chen X; Zhao J; Liu M; Lu Y
    Biomed Pharmacother; 2020 Nov; 131():110777. PubMed ID: 33152936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-proline-catalysed facile green protocol for the synthesis and antimycobacterial evaluation of [1,4]-thiazines.
    Indumathi S; Perumal S; Banerjee D; Yogeeswari P; Sriram D
    Eur J Med Chem; 2009 Dec; 44(12):4978-84. PubMed ID: 19781824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
    Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, syntheses, and anti-tuberculosis activities of conjugates of piperazino-1,3-benzothiazin-4-ones (pBTZs) with 2,7-dimethylimidazo [1,2-a]pyridine-3-carboxylic acids and 7-phenylacetyl cephalosporins.
    Majewski MW; Tiwari R; Miller PA; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2068-71. PubMed ID: 26951749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitubercular screening of some novel 4H-1,4- benzothiazines and their sulfones under environment benign solvent free conditions as future anti-tubercular agents.
    Guleria A; Jangid DK; Gautam N; Lakhotia R; Chowdhary A; Gautam DC
    Comb Chem High Throughput Screen; 2015; 18(1):48-52. PubMed ID: 25426761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benzothiazinones kill Mycobacterium tuberculosis by blocking arabinan synthesis.
    Makarov V; Manina G; Mikusova K; Möllmann U; Ryabova O; Saint-Joanis B; Dhar N; Pasca MR; Buroni S; Lucarelli AP; Milano A; De Rossi E; Belanova M; Bobovska A; Dianiskova P; Kordulakova J; Sala C; Fullam E; Schneider P; McKinney JD; Brodin P; Christophe T; Waddell S; Butcher P; Albrethsen J; Rosenkrands I; Brosch R; Nandi V; Bharath S; Gaonkar S; Shandil RK; Balasubramanian V; Balganesh T; Tyagi S; Grosset J; Riccardi G; Cole ST
    Science; 2009 May; 324(5928):801-4. PubMed ID: 19299584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antimycobacterial activity of new benzothiazinones inspired by rifampicin/rifapentine.
    Wang A; Lu Y; Lv K; Ma C; Xu S; Wang B; Wang A; Xia G; Liu M
    Bioorg Chem; 2020 Sep; 102():104135. PubMed ID: 32736151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones.
    Nosova EV; Lipunova GN; Charushin VN; Chupakhin ON
    Mini Rev Med Chem; 2019; 19(12):999-1014. PubMed ID: 30324881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards a new combination therapy for tuberculosis with next generation benzothiazinones.
    Makarov V; Lechartier B; Zhang M; Neres J; van der Sar AM; Raadsen SA; Hartkoorn RC; Ryabova OB; Vocat A; Decosterd LA; Widmer N; Buclin T; Bitter W; Andries K; Pojer F; Dyson PJ; Cole ST
    EMBO Mol Med; 2014 Mar; 6(3):372-83. PubMed ID: 24500695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and antimycobacterial activity of less lipophilic Q203 derivatives containing alkaline fused ring moieties.
    Wang A; Wang H; Geng Y; Fu L; Gu J; Wang B; Lv K; Liu M; Tao Z; Ma C; Lu Y
    Bioorg Med Chem; 2019 Mar; 27(5):813-821. PubMed ID: 30692025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety.
    Wang A; Du N; Song H; Zhang Y; Zhong X; Wu J; Xue T; Liu M; Wang B; Lv K; Lu Y
    Eur J Med Chem; 2023 Oct; 258():115545. PubMed ID: 37300914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of 1,3-thiazine derivatives and their evaluation as potential antimycobacterial agents.
    Koketsu M; Tanaka K; Takenaka Y; Kwong CD; Ishihara H
    Eur J Pharm Sci; 2002 Apr; 15(3):307-10. PubMed ID: 11923063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.